MedCity News July 11, 2024
Solving three major challenges in the development of new oncology drugs
Oncology is a critical area of healthcare, posing significant challenges yet offering substantial opportunities for innovation, particularly in pharma drug development. The seriousness of cancer is universal, with nearly everyone knowing someone affected by this daunting diagnosis.
Cancer is a leading cause of death in the US, with approximately 2 million new cases diagnosed annually and around 600,000 deaths each year. The financial burden is also significant, with the cost of cancer care exceeding $200 billion in 2020. Since then, the cost of cancer treatment has only increased due to increasing prevalence and novel, often expensive, treatments that have been introduced.
From a pharma standpoint, oncology drugs...
Today's Sponsors
Today's Sponsor